200 related articles for article (PubMed ID: 7586519)
1. Identification and quantification of intermediates of unsaturated fatty acid metabolism in plasma of patients with fatty acid oxidation disorders.
Onkenhout W; Venizelos V; van der Poel PF; van den Heuvel MP; Poorthuis BJ
Clin Chem; 1995 Oct; 41(10):1467-74. PubMed ID: 7586519
[TBL] [Abstract][Full Text] [Related]
2. Cis-4-decenoic acid in plasma: a characteristic metabolite in medium-chain acyl-CoA dehydrogenase deficiency.
Duran M; Bruinvis L; Ketting D; de Klerk JB; Wadman SK
Clin Chem; 1988 Mar; 34(3):548-51. PubMed ID: 3349606
[TBL] [Abstract][Full Text] [Related]
3. Rapid diagnosis of medium-chain acyl CoA dehydrogenase deficiency by measurement of cis-4-decenoic acid in plasma.
Heales SJ; Woolf DA; Robinson P; Leonard JV
J Inherit Metab Dis; 1991; 14(5):661-7. PubMed ID: 1779611
[TBL] [Abstract][Full Text] [Related]
4. Population screening for medium-chain acyl-CoA dehydrogenase deficiency: analysis of medium-chain fatty acids and acylglycines in blood spots.
Bennett MJ; Ragni MC; Ostfeld RJ; Santer R; Schmidt-Sommerfeld E
Ann Clin Biochem; 1994 Jan; 31 ( Pt 1)():72-7. PubMed ID: 8154855
[TBL] [Abstract][Full Text] [Related]
5. Diagnosis of medium chain acyl CoA dehydrogenase deficiency by measurement of cis-4-decenoic acid in dried blood spots.
Heales SJ; Leonard JV
Clin Chim Acta; 1992 Jul; 209(1-2):61-6. PubMed ID: 1395039
[TBL] [Abstract][Full Text] [Related]
6. Plasma free fatty acids in mitochondrial fatty acid oxidation defects.
Martínez G; Jiménez-Sánchez G; Divry P; Vianey-Saban C; Riudor E; Rodés M; Briones P; Ribes A
Clin Chim Acta; 1997 Nov; 267(2):143-54. PubMed ID: 9469249
[TBL] [Abstract][Full Text] [Related]
7. Production and disposal of medium-chain fatty acids in children with medium-chain acyl-CoA dehydrogenase deficiency.
Heales SJ; Thompson GN; Massoud AF; Rahman S; Halliday D; Leonard JV
J Inherit Metab Dis; 1994; 17(1):74-80. PubMed ID: 8051939
[TBL] [Abstract][Full Text] [Related]
8. Simultaneous analysis of plasma free fatty acids and their 3-hydroxy analogs in fatty acid beta-oxidation disorders.
Costa CG; Dorland L; Holwerda U; de Almeida IT; Poll-The BT; Jakobs C; Duran M
Clin Chem; 1998 Mar; 44(3):463-71. PubMed ID: 9510849
[TBL] [Abstract][Full Text] [Related]
9. Octanoic acidemia and octanoylcarnitine excretion with dicarboxylic aciduria due to defective oxidation of medium-chain fatty acids.
Duran M; Mitchell G; de Klerk JB; de Jager JP; Hofkamp M; Bruinvis L; Ketting D; Saudubray JM; Wadman SK
J Pediatr; 1985 Sep; 107(3):397-404. PubMed ID: 4032135
[TBL] [Abstract][Full Text] [Related]
10. Oxidation of unsaturated fatty acids by human fibroblasts with very-long-chain acyl-CoA dehydrogenase deficiency: aspects of substrate specificity and correlation with clinical phenotype.
Roe DS; Vianey-Saban C; Sharma S; Zabot MT; Roe CR
Clin Chim Acta; 2001 Oct; 312(1-2):55-67. PubMed ID: 11580910
[TBL] [Abstract][Full Text] [Related]
11. General (medium-chain) acyl-CoA dehydrogenase deficiency (non-ketotic dicarboxylic aciduria): quantitative urinary excretion pattern of 23 biologically significant organic acids in three cases.
Gregersen N; Kølvraa S; Rasmussen K; Mortensen PB; Divry P; David M; Hobolth N
Clin Chim Acta; 1983 Aug; 132(2):181-91. PubMed ID: 6616873
[TBL] [Abstract][Full Text] [Related]
12. Plasma cis-dec-4-enoic acid measured by isotope dilution mass spectrometry; an improved assay to diagnose medium-chain acyl-CoA dehydrogenase deficiency.
Johnson DW; Harrison JR; Norton WA; Poulos A; Robertson EF
J Inherit Metab Dis; 1994; 17(5):554-9. PubMed ID: 7837761
[TBL] [Abstract][Full Text] [Related]
13. A sensitive and simplified method to analyze free fatty acids in children with mitochondrial beta oxidation disorders using gas chromatography/mass spectrometry and dried blood spots.
Kimura M; Yoon HR; Wasant P; Takahashi Y; Yamaguchi S
Clin Chim Acta; 2002 Feb; 316(1-2):117-21. PubMed ID: 11750281
[TBL] [Abstract][Full Text] [Related]
14. Intermediates of unsaturated fatty acid oxidation are incorporated in triglycerides but not in phospholipids in tissues from patients with mitochondrial beta-oxidation defects.
Onkenhout W; Venizelos V; Scholte HR; De Klerk JB; Poorthuis BJ
J Inherit Metab Dis; 2001 Jun; 24(3):337-44. PubMed ID: 11486898
[TBL] [Abstract][Full Text] [Related]
15. Abnormal urinary excretion of unsaturated dicarboxylic acids in patients with medium-chain acyl-CoA dehydrogenase deficiency.
Tserng KY; Jin SJ; Kerr DS; Hoppel CL
J Lipid Res; 1990 May; 31(5):763-71. PubMed ID: 2380628
[TBL] [Abstract][Full Text] [Related]
16. Determination of total fatty acids in plasma: cis-5-tetradecenoic acid (C14:1 omega-9) in the diagnosis of long-chain fatty acid oxidation defects.
Divry P; Vianey-Saban C; Mathieu M
J Inherit Metab Dis; 1999 May; 22(3):286-8. PubMed ID: 10384388
[No Abstract] [Full Text] [Related]
17. Biochemical diagnosis of fatty acid oxidation disorders by metabolite analysis of postmortem liver.
Boles RG; Martin SK; Blitzer MG; Rinaldo P
Hum Pathol; 1994 Aug; 25(8):735-41. PubMed ID: 8056418
[TBL] [Abstract][Full Text] [Related]
18. Long-chain acyl-CoA dehydrogenase is a key enzyme in the mitochondrial beta-oxidation of unsaturated fatty acids.
Lea W; Abbas AS; Sprecher H; Vockley J; Schulz H
Biochim Biophys Acta; 2000 May; 1485(2-3):121-8. PubMed ID: 10832093
[TBL] [Abstract][Full Text] [Related]
19. Mutation analysis in mitochondrial fatty acid oxidation defects: Exemplified by acyl-CoA dehydrogenase deficiencies, with special focus on genotype-phenotype relationship.
Gregersen N; Andresen BS; Corydon MJ; Corydon TJ; Olsen RK; Bolund L; Bross P
Hum Mutat; 2001 Sep; 18(3):169-89. PubMed ID: 11524729
[TBL] [Abstract][Full Text] [Related]
20. Gas chromatography--mass spectrometry (GC--MS) diagnosis of two cases of medium chain acyl-CoA dehydrogenase deficiency.
Divry P; Vianey-Liaud C; Cotte J
J Inherit Metab Dis; 1984; 7 Suppl 1():44-7. PubMed ID: 6434844
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
